共 50 条
- [3] The SF-6Dv2: How Does the New Classification System Impact the Distribution of Responses Compared with the Original SF-6D? [J]. PharmacoEconomics, 2020, 38 : 1283 - 1288
- [6] A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population [J]. PharmacoEconomics, 2021, 39 : 929 - 940
- [7] Correction to: A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population [J]. PharmacoEconomics, 2022, 40 : 139 - 139
- [10] Comparison of four approaches in eliciting health state utilities with SF-6Dv2 [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2024,